What portal-based care means in practice: you won't have synchronous video calls as your primary clinical interaction
These metabolic improvements not only support effective weight loss but also reduce long-term risks associated with diabetes, heart disease, and obesity-related complications
A CNN report indicates that almost 60% of patients stayed on their GLP1 for less than 12 weeks
GLP-1 receptor agonists: A clinical perspective on cardiovascular effects
Lets commit to closing the loop: keep patients engaged, dosing consistently, supported holistically, and deliver the life-changing outcomes these therapies offer.
For patients, it lowers the barrier to starting advanced therapies, especially for those hesitant about injections